Ticker: ARWR

Company: ARROWHEAD PHARMACEUTICALS, INC.

Person: MICHAEL S PERRY, director

Transaction date: Aug. 18, 2026

Reporting date: Aug. 20, 2026

Average share price: 87.3

Sold 11600.0 shares for 1012680.0